BACKGROUND: Genetic variants in components or regulators of the RAS-MAPK signaling pathway are causative for severe and early-onset hypertrophic cardiomyopathy (HCM) in patients with Noonan syndrome ...
Hypertrophic cardiomyopathy (HCM), a common genetic heart disorder, is often caused by mutations in sarcomere-related genes. While extensively studied in European populations, its genetic basis in ...
In this cross-sectional study including 1 825 patients with HCM, Chinese patients have a higher proportion of rare variants but have a similar proportion of likely pathogenic or pathogenic variants ...
MEDICAL ALERT. IT’S A CONDITION THAT MANY PEOPLE HAVE BUT DON’T KNOW IT. HYPERTROPHIC CARDIOMYOPATHY. IT’S THE MOST COMMON GENETIC HEART CONDITION IN THE US, AND IT CAN BE DEADLY. IT’S OFTEN CALLED A ...
A small panel of circulating biomarkers may reliably distinguish hypertrophic cardiomyopathy (HCM) from similar conditions that cause left ventricular hypertrophy (LVH), researchers found. From ...
Hosted on MSN
Once-daily pill could help teens with common genetic heart disease, CHOP-led study finds
A once-daily pill could change how doctors treat teens with hypertrophic cardiomyopathy, a genetic heart condition that can block blood flow, a Philadelphia researcher has found. Children’s Hospital ...
It’s often silent but can be a deadly killer. Hypertrophic cardiomyopathy is a genetic condition that occurs in 1 in 500 people. Dr. Said Alsidawi, a Mayo Clinic cardiologist, says the problem is that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results